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la a total of 63 stool ....,._ frola 36 ,.aieats wltb portal layperteasioe ltadled, 
... prodaclaa ......._ were aron m. 33 per ceat of tbe _,... Wldle 
88 per ceat of tile orpdtaa8 were -..riiiYe to aeom.Jda, oaly .fO per ceat wwe 
llellllthe to .-pldiDa (P<0·005). It Is tbereb'e IIIIPited tlaat .......,. 
llloald be prefmed to aspldDia ID tbe treat.eat of llepatle eac:epbalopdltJ. 
Hepatic encephalopathy is the result 
of metabolic insults occurring in patients 
with liver disease. The striking improve-
ment with non-absorable antibioticsl-4 
suggests a major role for the bacterial 
degradation of nitrogenous intestinal con-
tents in the etiopathogenesis of hepatic 
coma. 
The efficacy of neomycin in hepatic 
encephalopathy was highlighted3 as early 
as in 1957. The azotemia associated with 
aome fonru; of severe liver diseaseS mili-
tates against the use of neomycin in these 
circumstances6-8. The usefulness of ampi-
cillin has been reported and the anti-
biotic has been suggested to be a satis-
factory substitute9•1o. However, no study 
has directly compared the efficacy of 
patients suffering from portal hyper· 
tension. The present study was under· 
taken to see the relative efficacy of ampi-
cillin and neomycin in the treatment or 
hepatic encephalopathy cases on the basil 
of the sensitivity pattern of the urease 
producing organism~; isolated from their 
gut. 
Material 11111 Medlods 
Thirty six patients prone to develop 
hepatic encephalopathy and suft'erina 
from a variety of hepatic diseases ~ere 
studied. Five of them were cirrhotic, 
9 had non-cirrhotic portal fibrosis, 6 
extrahepatic portal obstruction, .S had 
hepatic outftow obstruction and 11 had 
alcoholic liver disease. 
ampicillin over neomycin in the treatment One to five stool samples from each 
of hepatic ~opathy. Further, no patient were collected in buffered slY· 
study has been done directly comparing cerol saline and inoculated into Mac-
the In vitro sensitivity of urease producing Conkey's agar and de10xycholate citr&te 
orpnisms isolated from the faeces of agar plates. Mter incubatina ovemiabt 
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at 3'r'C, the colonies of lactose and non-
lactose fermenters were picked up and 
subjected to the following tests for identi-
fication : indole, methyl red, citrate uti-
lization, urea hydrolysis, Vogers-Prau:;ker 
reaction, and triple sugar iron slope. The 
identification of the urease producing 
organisms was done by routine methods. 
The antibiotic sensitivity of the urease 
producing organism was performed by 
the disc diffusion methodll, using discs 
of streptomycin (SO 1'8) chloramphenicol 
(50 1'8) tetracycline (SO l'g) ampicillin 
(10 fiB) gentamycin (10 1'8), neomycin (SO 
14g) and kanamycin (SO !'g). 
Results and Discussion 
Total number of patients included in 
the study were thirty six. Adequate sample 
for processing was available in only 35 
patients. Sixteen of the 35 patients (46~~) 
had urease producing. organisms in their 
stool. In all, 68 samples were received, 
of which only 63 could be processed. 
Of the 63 samples processed, 21 (33%) 
grew urease producing organisms while 
3 (5~{) showed salmonella species .1nd 
39 (62~~) were sterile. 
A single organism was isolated in 17 
samples of which l 5 (88%) were kleb-
siella and 2 (12%) proteus. Both klebsiella 
and proteus were present in 4 samples. 
Excluding the three samples showing 
salmonella, the 25 urease-producing or-
ganisms revealed antibiotic sensitivity, 
as shown in the Table. All the organisms 
were sensitive to gentamycin although 
two were only moderately sensitive. Sixty 
per cent of the organisms were resistant 
to ampicillin while only 12 per cent were 
resistant to neomycin. 
These results indicate a definite superi-
ority of neomycin over ampicillin 
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Table. The sensitivity of urease producins 
organisms to ampicillin and neomycin 
No. of urease 
Sensitivity 
producing 
organisms 
tested Sensitive Resis- Resistant to 
against tant ------
1 drua 2-3 4-S 
only druBS drugs 
AmpiciiJin 10 IS s• 2• s• 
(~/,;) (60%) 
Neomycin 22 3 Ot 
(88%) (12%) 
Resistance to ampicillin•;neomycint along with 
any of following drugs in order of frequency: 
tetracycline, chloramphcoicol, streptomycin. kana-
mycin. Resistance to both ampicillin and neomy-
cin was found in only one orpnism 
(P<0-005 by X2 test). It is known that 
there is considerable resistance amongst in-
testinal organisms against multiple anti-
biotics by the acquisition of R-plasmids. 
However, the short term llSC of non-
absorable antibiotioa in patients with 
hepatic coma has been shown to produce 
l>triking improvement in enccphalopathy4. 
A comparative in vitro study of neomycin 
and ampicillin against urease producing 
organisms has not been reported before. 
The study of MeyerslO concerns itself 
only with the effectiveness of ampicillin 
in reduction of gastric ammonia pro-
duction and ammonia released from the 
colon was not studied. The clinical use-
fulness of ampicillin reported by Tandon 
and associates9 utilised a number of other 
measures along with ampicillin, which 
were used empcrically and no di~t 
comparison with neomycin w•n made. 
Neomycla ... a.mpidlUa apitst urease producers 
We suggest that neomycin may be 
superior to ampicillin in the treatment 
of hepatic encephalopathy in the absence 
of azotemia. 
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